AFP-Scan
Alternative Names: ImmuRAID AFP Tc 99mLatest Information Update: 27 Oct 2020
At a glance
- Originator Immunomedics
- Class Imaging agents; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 23 Oct 2020 Immunomedics has been acquired by Gilead Sciences
- 01 Jul 2003 This programme is still in active development
- 11 Sep 2001 Immunomedics has received orphan drug designation for AFP-Scan for liver and germ-cell cancer imaging